Optiscan Imaging Limited (ASX:OIL)

Market Cap	156.63M +120.6%
Revenue (ttm)	3.61M -3.0%
Net Income	-6.99M
EPS	-0.01
Shares Out	1.04B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	236,976
Open	0.1500
Previous Close	0.1500
Day's Range	0.1400 - 0.1550
52-Week Range	0.0800 - 0.2000
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Optiscan Imaging

Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1994
• Employees: 9
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OIL

Financial Performance

In fiscal year 2026, Optiscan Imaging's revenue was 3.61 million, a decrease of -2.98% compared to the previous year's 3.72 million. Losses were -6.99 million, 10.7% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 8, 2026

Data Sources Report a data error